Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Selective D2 and D3 receptor antagonists oppositely modulate cocaine responses in mice via distinct postsynaptic mechanisms in nucleus accumbens.

Manvich DF, Petko AK, Branco RC, Foster SL, Porter-Stransky KA, Stout KA, Newman AH, Miller GW, Paladini CA, Weinshenker D.

Neuropsychopharmacology. 2019 Mar 16. doi: 10.1038/s41386-019-0371-2. [Epub ahead of print]

PMID:
30879021
2.

Transient and rapid activation of Akt/GSK-3β and mTORC1 signaling by D3 dopamine receptor stimulation in dorsal striatum and nucleus accumbens.

Salles MJ, Hervé D, Rivet JM, Longueville S, Millan MJ, Girault JA, Mannoury la Cour C.

J Neurochem. 2013 May;125(4):532-44. doi: 10.1111/jnc.12206. Epub 2013 Mar 11.

3.

Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice.

Le Foll B, Francès H, Diaz J, Schwartz JC, Sokoloff P.

Eur J Neurosci. 2002 Jun;15(12):2016-26.

PMID:
12099907
4.

Differential effects of the dopamine D3 receptor antagonist PG01037 on cocaine and methamphetamine self-administration in rhesus monkeys.

John WS, Newman AH, Nader MA.

Neuropharmacology. 2015 May;92:34-43. doi: 10.1016/j.neuropharm.2014.12.024. Epub 2015 Jan 6.

5.

Dopamine D3/D2 Receptor Antagonist PF-4363467 Attenuates Opioid Drug-Seeking Behavior without Concomitant D2 Side Effects.

Wager TT, Chappie T, Horton D, Chandrasekaran RY, Samas B, Dunn-Sims ER, Hsu C, Nawreen N, Vanase-Frawley MA, O'Connor RE, Schmidt CJ, Dlugolenski K, Stratman NC, Majchrzak MJ, Kormos BL, Nguyen DP, Sawant-Basak A, Mead AN.

ACS Chem Neurosci. 2017 Jan 18;8(1):165-177. doi: 10.1021/acschemneuro.6b00297. Epub 2016 Oct 21.

PMID:
27715007
6.

Coexpression of dopamine D1 and D3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions.

Ridray S, Griffon N, Mignon V, Souil E, Carboni S, Diaz J, Schwartz JC, Sokoloff P.

Eur J Neurosci. 1998 May;10(5):1676-86.

PMID:
9751140
8.

Contributions of dopamine D1, D2, and D3 receptor subtypes to the disruptive effects of cocaine on prepulse inhibition in mice.

Doherty JM, Masten VL, Powell SB, Ralph RJ, Klamer D, Low MJ, Geyer MA.

Neuropsychopharmacology. 2008 Oct;33(11):2648-56. Epub 2007 Dec 12.

9.

Mechanisms of Kappa Opioid Receptor Potentiation of Dopamine D2 Receptor Function in Quinpirole-Induced Locomotor Sensitization in Rats.

Escobar AP, González MP, Meza RC, Noches V, Henny P, Gysling K, España RA, Fuentealba JA, Andrés ME.

Int J Neuropsychopharmacol. 2017 Aug 1;20(8):660-669. doi: 10.1093/ijnp/pyx042.

10.

Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists.

Caine SB, Negus SS, Mello NK, Patel S, Bristow L, Kulagowski J, Vallone D, Saiardi A, Borrelli E.

J Neurosci. 2002 Apr 1;22(7):2977-88.

11.

Dopamine D3 Receptor Modulates l-DOPA-Induced Dyskinesia by Targeting D1 Receptor-Mediated Striatal Signaling.

Solís O, Garcia-Montes JR, González-Granillo A, Xu M, Moratalla R.

Cereb Cortex. 2017 Jan 1;27(1):435-446. doi: 10.1093/cercor/bhv231.

12.

Dopamine D3 autoreceptor inhibition enhances cocaine potency at the dopamine transporter.

McGinnis MM, Siciliano CA, Jones SR.

J Neurochem. 2016 Sep;138(6):821-9. doi: 10.1111/jnc.13732. Epub 2016 Aug 15.

13.

Regional and source-based patterns of [11C]-(+)-PHNO binding potential reveal concurrent alterations in dopamine D2 and D3 receptor availability in cocaine-use disorder.

Worhunsky PD, Matuskey D, Gallezot JD, Gaiser EC, Nabulsi N, Angarita GA, Calhoun VD, Malison RT, Potenza MN, Carson RE.

Neuroimage. 2017 Mar 1;148:343-351. doi: 10.1016/j.neuroimage.2017.01.045. Epub 2017 Jan 19.

14.

Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens.

Rouillon C, Degoulet M, Chevallier K, Abraini JH, David HN.

Brain Res. 2008 Mar 10;1198:44-54. doi: 10.1016/j.brainres.2008.01.025. Epub 2008 Jan 18.

PMID:
18261716
16.

Effect of optogenetic manipulation of accumbal medium spiny neurons expressing dopamine D2 receptors in cocaine-induced behavioral sensitization.

Kang BJ, Song SS, Wen L, Hong KP, Augustine GJ, Baik JH.

Eur J Neurosci. 2017 Aug;46(4):2056-2066. doi: 10.1111/ejn.13648. Epub 2017 Aug 9.

PMID:
28708260
17.

Selective dopamine D3 receptor antagonist YQA14 inhibits morphine-induced behavioral sensitization in wild type, but not in dopamine D3 receptor knockout mice.

Lv Y, Hu RR, Jing M, Zhao TY, Wu N, Song R, Li J, Hu G.

Acta Pharmacol Sin. 2018 Sep 17. doi: 10.1038/s41401-018-0153-0. [Epub ahead of print]

PMID:
30224637
18.

Differential roles of dopamine D1 and D2 receptor-containing neurons of the nucleus accumbens shell in behavioral sensitization.

Kai N, Nishizawa K, Tsutsui Y, Ueda S, Kobayashi K.

J Neurochem. 2015 Dec;135(6):1232-41. doi: 10.1111/jnc.13380. Epub 2015 Oct 28.

19.

Targeting the dopamine D3 receptor: an overview of drug design strategies.

Cortés A, Moreno E, Rodríguez-Ruiz M, Canela EI, Casadó V.

Expert Opin Drug Discov. 2016 Jul;11(7):641-64. doi: 10.1080/17460441.2016.1185413. Epub 2016 May 30. Review.

PMID:
27135354
20.

Reduction of cocaine self-administration and D3 receptor-mediated behavior by two novel dopamine D3 receptor-selective partial agonists, OS-3-106 and WW-III-55.

Cheung TH, Loriaux AL, Weber SM, Chandler KN, Lenz JD, Schaan RF, Mach RH, Luedtke RR, Neisewander JL.

J Pharmacol Exp Ther. 2013 Nov;347(2):410-23. doi: 10.1124/jpet.112.202911. Epub 2013 Sep 9.

Supplemental Content

Support Center